title: Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte recovery after auto-SCT in patient with end-stage renal-disease.
authors.forename: D
authors.initials: D
authors.lastname: Dunn
authors.forename: P
authors.initials: P
authors.lastname: Vikas
authors.forename: M
authors.initials: M
authors.lastname: Jagasia
authors.forename: B N
authors.initials: BN
authors.lastname: Savani
mesh_terms: D000682:Amyloid / Q000097:blood; D000686:Amyloidosis / Q000097:blood / Q000150:complications / Q000628:therapy; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D001596:Benzylamines; D000080027:Cyclams; D005260:Female; D019650:Hematopoietic Stem Cell Mobilization; D006571:Heterocyclic Compounds / Q000008:administration & dosage*; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000097:blood; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications / Q000628:therapy; D008214:Lymphocytes; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D012074:Remission Induction; D014182:Transplantation, Autologous
chemical_list: D000682:Amyloid; D019380:Anti-HIV Agents; D001596:Benzylamines; D000080027:Cyclams; D006571:Heterocyclic Compounds; D007147:Immunoglobulin Light Chains; C088327:plerixafor